LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Actuate Therapeutics (NASDAQ: ACTU)

Follow NASDAQ:ACTU Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACTU Actuate Therapeutics
Bios Equity COF, LP / director, 10 percent owner:
06/27/2025
Buy
$7.00
71,428
$500K
196,428
NASDAQ ACTU Actuate Therapeutics
Bios Equity COF, LP / director, 10 percent owner:
06/27/2025
Buy
$7.00
71,428
$500K
71,428
NASDAQ ACTU Actuate Therapeutics
Kreis Leslie W. / director, 10 percent owner:
06/27/2025
Buy
$7.00
71,428
$500K
196,428
NASDAQ ACTU Actuate Therapeutics
Kreis Leslie W. / director, 10 percent owner:
06/27/2025
Buy
$7.00
71,428
$500K
71,428
NASDAQ ACTU Actuate Therapeutics
Fletcher Aaron G.L. / director, 10 percent owner:
06/27/2025
Buy
$7.00
71,428
$500K
196,428
NASDAQ ACTU Actuate Therapeutics
Fletcher Aaron G.L. / director, 10 percent owner:
06/27/2025
Buy
$7.00
71,428
$500K
71,428
NASDAQ ACTU Actuate Therapeutics
THOMSON TODD S / director, 10 percent owner:
05/22/2025
Buy
$10.10
15,000
$152K
15,000
NASDAQ ACTU Actuate Therapeutics
Sawhney Roger / director
05/22/2025
Buy
$10.10
15,000
$152K
15,000
NASDAQ ACTU Actuate Therapeutics
Zabrowski Dan / director
05/22/2025
Buy
$10.10
15,000
$152K
15,000
NASDAQ ACTU Actuate Therapeutics
Fletcher Aaron G.L. / director, 10 percent owner:
05/22/2025
Buy
$10.10
15,000
$152K
15,000
NASDAQ ACTU Actuate Therapeutics
Keyes Jason A / director
05/22/2025
Buy
$10.10
15,000
$152K
15,000
NASDAQ ACTU Actuate Therapeutics
RONNEBERG AMY L / director
05/22/2025
Buy
$10.10
15,000
$152K
15,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous